These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23010432)

  • 1. A novel homozygous mutation in SUCLA2 gene identified by exome sequencing.
    Lamperti C; Fang M; Invernizzi F; Liu X; Wang H; Zhang Q; Carrara F; Moroni I; Zeviani M; Zhang J; Ghezzi D
    Mol Genet Metab; 2012 Nov; 107(3):403-8. PubMed ID: 23010432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
    Carrozzo R; Verrigni D; Rasmussen M; de Coo R; Amartino H; Bianchi M; Buhas D; Mesli S; Naess K; Born AP; Woldseth B; Prontera P; Batbayli M; Ravn K; Joensen F; Cordelli DM; Santorelli FM; Tulinius M; Darin N; Duno M; Jouvencel P; Burlina A; Stangoni G; Bertini E; Redonnet-Vernhet I; Wibrand F; Dionisi-Vici C; Uusimaa J; Vieira P; Osorio AN; McFarland R; Taylor RW; Holme E; Ostergaard E
    J Inherit Metab Dis; 2016 Mar; 39(2):243-52. PubMed ID: 26475597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
    Carrozzo R; Dionisi-Vici C; Steuerwald U; Lucioli S; Deodato F; Di Giandomenico S; Bertini E; Franke B; Kluijtmans LA; Meschini MC; Rizzo C; Piemonte F; Rodenburg R; Santer R; Santorelli FM; van Rooij A; Vermunt-de Koning D; Morava E; Wevers RA
    Brain; 2007 Mar; 130(Pt 3):862-74. PubMed ID: 17301081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUCLG1 mutations and mitochondrial encephalomyopathy: a case study and review of the literature.
    Molaei Ramsheh S; Erfanian Omidvar M; Tabasinezhad M; Alipoor B; Salmani TA; Ghaedi H
    Mol Biol Rep; 2020 Dec; 47(12):9699-9714. PubMed ID: 33230783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.
    Ostergaard E; Hansen FJ; Sorensen N; Duno M; Vissing J; Larsen PL; Faeroe O; Thorgrimsson S; Wibrand F; Christensen E; Schwartz M
    Brain; 2007 Mar; 130(Pt 3):853-61. PubMed ID: 17287286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SUCLA2-related encephalomyopathic mitochondrial DNA depletion syndrome: a case report and review of literature].
    Liu Z; Fang F; Ding C; Wu H; Lyu J; Wu Y
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):817-21. PubMed ID: 25582465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Molecular, and Computational Analysis in two cases with mitochondrial encephalomyopathy associated with SUCLG1 mutation in a consanguineous family.
    Maalej M; Tej A; Bouguila J; Tilouche S; Majdoub S; Khabou B; Tabbebi M; Felhi R; Ammar M; Mkaouar-Rebai E; Keskes L; Boughamoura L; Fakhfakh F
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1730-1737. PubMed ID: 29217198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation in SUCLA2 identified on sequencing analysis.
    Güngör O; Özkaya AK; Güngör G; Karaer K; Dilber C; Aydin K
    Pediatr Int; 2016 Jul; 58(7):659-61. PubMed ID: 26952923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion.
    Elpeleg O; Miller C; Hershkovitz E; Bitner-Glindzicz M; Bondi-Rubinstein G; Rahman S; Pagnamenta A; Eshhar S; Saada A
    Am J Hum Genet; 2005 Jun; 76(6):1081-6. PubMed ID: 15877282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion.
    Matilainen S; Isohanni P; Euro L; Lönnqvist T; Pihko H; Kivelä T; Knuutila S; Suomalainen A
    Eur J Hum Genet; 2015 Mar; 23(3):325-30. PubMed ID: 24986829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in FBXL4 in a Norwegian child with encephalomyopathic mitochondrial DNA depletion syndrome 13.
    Barøy T; Pedurupillay CR; Bliksrud YT; Rasmussen M; Holmgren A; Vigeland MD; Hughes T; Brink M; Rodenburg R; Nedregaard B; Strømme P; Frengen E; Misceo D
    Eur J Med Genet; 2016 Jun; 59(6-7):342-6. PubMed ID: 27182039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria.
    Ostergaard E; Schwartz M; Batbayli M; Christensen E; Hjalmarson O; Kollberg G; Holme E
    Eur J Pediatr; 2010 Feb; 169(2):201-5. PubMed ID: 19526370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion.
    Huang X; Bedoyan JK; Demirbas D; Harris DJ; Miron A; Edelheit S; Grahame G; DeBrosse SD; Wong LJ; Hoppel CL; Kerr DS; Anselm I; Berry GT
    Mol Genet Metab; 2017 Mar; 120(3):213-222. PubMed ID: 27913098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein.
    Rouzier C; Le Guédard-Méreuze S; Fragaki K; Serre V; Miro J; Tuffery-Giraud S; Chaussenot A; Bannwarth S; Caruba C; Ostergaard E; Pellissier JF; Richelme C; Espil C; Chabrol B; Paquis-Flucklinger V
    J Med Genet; 2010 Oct; 47(10):670-6. PubMed ID: 20693550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance.
    Bonnen PE; Yarham JW; Besse A; Wu P; Faqeih EA; Al-Asmari AM; Saleh MA; Eyaid W; Hadeel A; He L; Smith F; Yau S; Simcox EM; Miwa S; Donti T; Abu-Amero KK; Wong LJ; Craigen WJ; Graham BH; Scott KL; McFarland R; Taylor RW
    Am J Hum Genet; 2013 Sep; 93(3):471-81. PubMed ID: 23993193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurring Down syndrome and SUCLA2-related mitochondrial depletion syndrome.
    Couser NL; Marchuk DS; Smith LD; Arreola A; Kaiser-Rogers KA; Muenzer J; Pandya A; Gucsavas-Calikoglu M; Powell CM
    Am J Med Genet A; 2017 Oct; 173(10):2720-2724. PubMed ID: 28749033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel mutation p.Asp251Asn in the β-subunit of succinate-CoA ligase causes encephalomyopathy and elevated succinylcarnitine.
    Jaberi E; Chitsazian F; Ali Shahidi G; Rohani M; Sina F; Safari I; Malakouti Nejad M; Houshmand M; Klotzle B; Elahi E
    J Hum Genet; 2013 Aug; 58(8):526-30. PubMed ID: 23759946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies.
    Diodato D; Melchionda L; Haack TB; Dallabona C; Baruffini E; Donnini C; Granata T; Ragona F; Balestri P; Margollicci M; Lamantea E; Nasca A; Powell CA; Minczuk M; Strom TM; Meitinger T; Prokisch H; Lamperti C; Zeviani M; Ghezzi D
    Hum Mutat; 2014 Aug; 35(8):983-9. PubMed ID: 24827421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder.
    Randolph LM; Jackson HA; Wang J; Shimada H; Sanchez-Lara PA; Wong DA; Wong LJ; Boles RG
    Mol Genet Metab; 2011 Feb; 102(2):149-52. PubMed ID: 21093335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNASEH1 Mutations Impair mtDNA Replication and Cause Adult-Onset Mitochondrial Encephalomyopathy.
    Reyes A; Melchionda L; Nasca A; Carrara F; Lamantea E; Zanolini A; Lamperti C; Fang M; Zhang J; Ronchi D; Bonato S; Fagiolari G; Moggio M; Ghezzi D; Zeviani M
    Am J Hum Genet; 2015 Jul; 97(1):186-93. PubMed ID: 26094573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.